Compare LMRI & TRUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMRI | TRUP |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2025 | 2014 |
| Metric | LMRI | TRUP |
|---|---|---|
| Price | $14.40 | $27.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $22.67 | ★ $45.50 |
| AVG Volume (30 Days) | ★ 541.2K | 511.8K |
| Earning Date | 01-01-0001 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.45 |
| Revenue | $1,003,375,000.00 | ★ $1,439,305,000.00 |
| Revenue This Year | $9.29 | $12.07 |
| Revenue Next Year | $5.01 | $8.68 |
| P/E Ratio | ★ N/A | $62.13 |
| Revenue Growth | 1.38 | ★ 11.95 |
| 52 Week Low | $9.97 | $27.30 |
| 52 Week High | $19.45 | $57.89 |
| Indicator | LMRI | TRUP |
|---|---|---|
| Relative Strength Index (RSI) | 51.20 | 25.33 |
| Support Level | $9.97 | $32.47 |
| Resistance Level | $14.15 | $34.42 |
| Average True Range (ATR) | 1.21 | 1.56 |
| MACD | 0.38 | -0.09 |
| Stochastic Oscillator | 86.21 | 9.27 |
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.